PFM Health Sciences, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$19,299,000
+128.4%
344,868
+111.2%
0.70%
+116.8%
Q2 2022$8,451,000
-59.6%
163,280
-43.3%
0.32%
-58.8%
Q1 2022$20,922,000
-0.7%
287,909
+61.5%
0.78%
+9.1%
Q4 2021$21,073,000
-11.9%
178,2220.0%0.72%
+2.0%
Q3 2021$23,908,000
-43.9%
178,222
-32.3%
0.70%
-47.3%
Q2 2021$42,618,000
+86.9%
263,222
-7.3%
1.34%
+91.8%
Q1 2021$22,801,000284,1010.70%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders